TrialJournal of pain research2024

Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States.

Gary Berman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.